Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohshin Washiyama

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|April 2, 2025
[New Investment for Theranostics in Europe]Kaori Nomura, Kohshin Washiyama, Noboru Oriuchi
Rhinology|November 26, 2009
Use of thallium transport to visualize functional olfactory nerve regeneration in vivoHideaki Shiga, Kohshin Washiyama, Kyoko Hirota, et al.
International Journal of Cancer|May 24, 2008
alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptideMitsuyoshi Yoshimoto, Kazuma Ogawa, Kohshin Washiyama, et al.
Nuclear Medicine and Biology|October 7, 2004
227Th-EDTMP: a potential therapeutic agent for bone metastasisKohshin Washiyama, Ryohei Amano, Jun Sasaki, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|October 23, 2015
[Manufacture and Utilization of a Low-level Radioactive 68Ge/68Ga Generator in a Radiochemistry Laboratory Course]Kohshin Washiyama, Ryohei Amano, Tadashi Nozaki, et al.
Cancer Science|August 8, 2009
Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapyKazuma Ogawa, Kazuhiro Shiba, Nasima Akhter, et al.
Chemical Senses|June 7, 2008
Odor detection ability and thallium-201 transport in the olfactory nerve of traumatic olfactory-impaired miceHideaki Shiga, Yayoi Kinoshita, Kohshin Washiyama, et al.
Nuclear Medicine and Biology|February 17, 2009
Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastasesKazuma Ogawa, Hidekazu Kawashima, Kazuhiro Shiba, et al.
Molecular Pharmaceutics|August 17, 2021
<sup>68</sup>Ga- and <sup>211</sup>At-Labeled RGD Peptides for Radiotheranostics with MultiradionuclidesKazuma Ogawa, Hiroaki Echigo, Kenji Mishiro, et al.
Nuclear Medicine and Biology|August 4, 2015
Preparation and evaluation of an astatine-211-labeled sigma receptor ligand for alpha radionuclide therapyKazuma Ogawa, Yoshiaki Mizuno, Kohshin Washiyama, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Kaku Igaku. the Japanese Journal of Nuclear Medicine|April 2, 2025
[New Investment for Theranostics in Europe]Kaori Nomura, Kohshin Washiyama, Noboru Oriuchi
Rhinology|November 26, 2009
Use of thallium transport to visualize functional olfactory nerve regeneration in vivoHideaki Shiga, Kohshin Washiyama, Kyoko Hirota, et al.
International Journal of Cancer|May 24, 2008
alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptideMitsuyoshi Yoshimoto, Kazuma Ogawa, Kohshin Washiyama, et al.
Nuclear Medicine and Biology|October 7, 2004
227Th-EDTMP: a potential therapeutic agent for bone metastasisKohshin Washiyama, Ryohei Amano, Jun Sasaki, et al.
Nihon Hoshasen Gijutsu Gakkai Zasshi|October 23, 2015
[Manufacture and Utilization of a Low-level Radioactive 68Ge/68Ga Generator in a Radiochemistry Laboratory Course]Kohshin Washiyama, Ryohei Amano, Tadashi Nozaki, et al.
Cancer Science|August 8, 2009
Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapyKazuma Ogawa, Kazuhiro Shiba, Nasima Akhter, et al.
Chemical Senses|June 7, 2008
Odor detection ability and thallium-201 transport in the olfactory nerve of traumatic olfactory-impaired miceHideaki Shiga, Yayoi Kinoshita, Kohshin Washiyama, et al.
Nuclear Medicine and Biology|February 17, 2009
Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastasesKazuma Ogawa, Hidekazu Kawashima, Kazuhiro Shiba, et al.
Molecular Pharmaceutics|August 17, 2021
<sup>68</sup>Ga- and <sup>211</sup>At-Labeled RGD Peptides for Radiotheranostics with MultiradionuclidesKazuma Ogawa, Hiroaki Echigo, Kenji Mishiro, et al.
Nuclear Medicine and Biology|August 4, 2015
Preparation and evaluation of an astatine-211-labeled sigma receptor ligand for alpha radionuclide therapyKazuma Ogawa, Yoshiaki Mizuno, Kohshin Washiyama, et al.
Pageof 4